GlassScriptPhysician profile
Christopher J Kondray
NPI 1487040168
$1,715.37
in general payments reported to CMS, 2019-2025
11 companies · $29.89 in 2025
The $29.89 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $372 · 2021: $291 · 2022: $243 · 2023: $268 · 2024: $511 · 2025: $29.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $283.76 | 2021-2022 | |
| Inari Medical, INC. | $267.06 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $256.13 | 2020-2022 | |
| Medtronic Vascular, INC. | $239.06 | 2020 | |
| Boston Scientific Corporation | $193.43 | 2020-2024 | |
| Sirtex Medical INC | $149.84 | 2024 | Sir-Spheres Microspheres |
| Angiodynamics, INC. | $139.48 | 2024 | Nanoknife |
| Penumbra, INC. | $86.00 | 2021 | |
| Cordis US Corp. | $45.90 | 2022-2023 | Mynx Control |
| Trisalus Life Sciences, INC. | $29.89 | 2025 | Trinav Infusion System |
| Cardiva Medical, INC. | $24.82 | 2024 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kondray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.